|
MARS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.01639999999737E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.1982999999266E-07 |
| Normal-vs-Stage2 |
5.198300E-04 |
| Normal-vs-Stage3 |
4.356300E-04 |
| Normal-vs-Stage4 |
9.390400E-01 |
| Stage1-vs-Stage2 |
7.714800E-01 |
| Stage1-vs-Stage3 |
4.111400E-01 |
| Stage1-vs-Stage4 |
5.537200E-03 |
| Stage2-vs-Stage3 |
7.694200E-01 |
| Stage2-vs-Stage4 |
1.854150E-02 |
| Stage3-vs-Stage4 |
2.204300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.08339999999696E-05 |
| Normal-vs-AfricanAmerican |
8.257700E-02 |
| Normal-vs-Asian |
4.619800E-01 |
| Caucasian-vs-AfricanAmerican |
1.717360E-01 |
| Caucasian-vs-Asian |
7.199800E-02 |
| AfricanAmerican-vs-Asian |
1.721830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.73539999999539E-05 |
| Normal-vs-Female |
1.356560E-03 |
| Male-vs-Female |
2.709800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.708160E-02 |
| Normal-vs-Age(41-60Yrs) |
3.188400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.965700E-04 |
| Normal-vs-Age(81-100Yrs) |
4.888200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.709800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.637200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.469400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.466000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.887000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.172400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.818400E-02 |
| Normal-vs-Grade 2 |
1.0201000000265E-07 |
| Normal-vs-Grade 3 |
5.67769999999523E-05 |
| Normal-vs-Grade 4 |
4.415200E-01 |
| Grade 1-vs-Grade 2 |
4.027200E-01 |
| Grade 1-vs-Grade 3 |
7.296400E-01 |
| Grade 1-vs-Grade 4 |
9.991500E-02 |
| Grade 2-vs-Grade 3 |
1.825560E-01 |
| Grade 2-vs-Grade 4 |
3.842900E-04 |
| Grade 3-vs-Grade 4 |
2.338400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.71851421981728E-12 |
| Normal-vs-ccB subtype |
6.172400E-02 |
| ccA subtype-vs-ccB subtype |
1.38569999919014E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.615100E-03 |
| Normal-vs-N1 |
2.984000E-01 |
| N0-vs-N1 |
1.140260E-02 |
|
|
